PM
TWST icon

Parametrica Management’s Twist Bioscience TWST Stock Holding History

Parametrica Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,386
Closed -$371K – 179
2021
Q1 		$371K Buy
+3,386
New +$514K 0.18% 95

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Parametrica Management's TWST Position: Q2 2021 in Review

Parametrica Management sold out of Twist Bioscience (TWST) in Q2 2021, closing a stake of 3,386 shares — an estimated $371K sold.

Parametrica Management first reported a position in TWST in Q1 2021 and held it in 1 quarter. The position peaked at $371K in Q1 2021. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2021.

  • Parametrica Management reported no remaining Twist Bioscience position as of Q2 2021 after selling out during the quarter.
  • Parametrica Management sold 3,386 Twist Bioscience shares in Q2 2021, an estimated $371K.
  • Parametrica Management first reported a position in Twist Bioscience in Q1 2021 and held it in 1 quarter.
  • Parametrica Management's Twist Bioscience position peaked at $371K in Q1 2021.
  • 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2021.

Based on Parametrica Management's 13F filing for Q2 2021, filed 13 Aug 2021.